how long have glp-1 been on the market 🔮 GLP-1s could transform society GLP-1 Market Size, Scope, Forecast

Ghrelin administration in the fed state increased OFC and hippocampus activation similar to fasting (i.e., endogenous ghrelinemia) (Goldstone et al., 2014)

February 5, 2025: Ozempic Lawsuits Surpass 1400 as More Consumers Speak Out About GLP-1 Complications Novo Nordisk and other GLP-1 drug makers are facing 1,443 lawsuits in the current federal multidistrict litigation against it

The effect is most noticeable during the active dose-escalation phase and the first few weeks at target dose

The ability of metformin to increase GLP-1 levels independently of effects on DPP-4 suggests there could be a direct benefit in terms of incretin action by combining metformin with DPP-4 inhibitors

January 6, 2026